Inovio Says Study Shows Robust Vaccine Antibody Response; Positive Results on Leukemia DNA Vaccine

by Benzinga Staff
December 6, 2012 2:03 PM | 20 seconds read | Make a Comment

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Inovio Pharmaceuticals, Inc.(NYSE MKT: INO) announced today that preliminary results of a phase IIclinical trial to treat leukemia with a WT1 DNA vaccine delivered withInovio's proprietary electroporation delivery system showed robustvaccine-specific antibody responses in all vaccinated subjects evaluated todate. Furthermore, T cell immune responses, including those of the "killer Tcells," were detected. Antibody and T cell responses are strong signals of theDNA vaccine's potential to treat the disease.

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: NewsFDALegal

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.